USPTO serial 79456083
GX ADHERALINK
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- FLETCHER, TRACY L
- Law office
- TMO LAW OFFICE 115
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with GX ADHERALINK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software; downloadable and non-downloadable software used to measure, store, collect, transmit, monitor and analyze data from drug delivery devices; software enabling automated and interactive messaging, including chatbot-based communication via third-party messaging platforms; software for integration with messaging services to enable natural language communication with patients without requiring application downloads; software for monitoring patient compliance, medication adherence, and device performance in connection with drug delivery devices; data processing programs; artificial intelligence software for healthcare; computer software for use as an application programming interface (API); wireless transmitters and receivers used with the foregoing; sensors. | ACTIVE | — |
| 010 | Medical apparatus and instruments; Medical devices; medical devices for storage, preparation and/or administration of a medical substance; drug delivery devices, in particular auto-injectors, pen injectors, syringes, vials, containers; medical devices incorporating software and sensors for monitoring drug delivery, in particular smart add-on monitoring modules for drug delivery devices, smart closure systems and smart caps; medical devices featuring artificial intelligence; electronic and/or internet-enabled medical devices for transmitting drug delivery data to servers, cloud-based systems and/or electronic end devices. | ACTIVE | — |
| 042 | Scientific and technological services; Computer software design and development; design and development of computer software for use in healthcare, medical device monitoring and patient support; design, development, maintenance, and updating of software for patient monitoring and medical device integration; hosting and cloud computing; hosting of databases and server infrastructures for patient-related drug intake data; software as a service (SaaS), platform as a service (PaaS); providing temporary use of non-downloadable software for managing medical device data and patient communications; software as a service (SaaS) for collecting, transmitting, storing, evaluating and monitoring data on medication intake; software as a service (SaaS) for the technical analysis of therapy-related user data; platform as a service (PaaS) for integrating smart medical devices with digital patient communication systems; technical data analysis; automated analysis of user and sensor data; artificial intelligence driven data analysis; provision of application programming interfaces (APIs); provision of technical interfaces (APIs) for connecting third-party applications for user-related output of information based on advice and recommendations; software for the encrypted and secure processing and transmission of medical data; provision of data protection-compliant software architectures; access control and authentication services; quality control. | ACTIVE | — |
| 044 | Medical services; Health care services; digital medical services; medical support and consulting services; data consultation services relating to medical information; medical information and consulting services provided via general messenger apps; digital medical consulting using artificial intelligence software; therapy-accompanying care; providing medical information and patient support related to drug delivery therapies; providing healthcare advisory services via automated digital communication platforms; patient engagement services to support adherence to prescribed medical treatments; health monitoring services; health monitoring services relating to patient compliance with prescribed drug treatments; automated analysis of user and sensor data for medical purposes; data analysis for medical purposes using artificial intelligence software; health risk assessment. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 27, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 22, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 1, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 16, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 14, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 13, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |